a (Baseline) Optical coherence tomography (OCT) directly after implantation of the bioresorbable scaffold (BVS). Adequate BVS expansion and focally malapposed struts in the distal 3-mm scaffold segment (white arrow) into right coronary artery. b (1-year follow-up) Uncovered stent struts (blue arrows) at 12 months after the intervention. c (2-year follow-up) 24-month OCT revealed complete coverage of all struts with a homogeneous, bright neointimal layer and resolved malapposition in the distal segment A 67-year-old male underwent primary percutaneous coronary intervention for inferior ST-segment elevation myocardial infarction. The patient further underwent aspiration thrombectomy, abciximab infusion and predilatation with subsequent implantation of two bioresorbable scaffolds followed by post-dilatation with a non-compliant balloon in the right coronary artery. The optical coherence tomography (OCT) confirmed good scaffold expansion, with focally malapposed struts in the distal 3-mm scaffold segment. Twelve months later, at the prespecified evaluation, the vessel was patent without evidence of restenosis or thrombus, however, the OCT revealed a substantial rate of uncovered struts (8.5%). Interestingly, all struts were covered by neointima at the 24-month examination. Based on these J. Kochman
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